“…In addition, daphnetin inhibits tyrosine kinase, epidermal growth factor receptor, serine/threonine-specific protein kinase, and protein kinase C in vitro [17]. On the other hand, thiazole [18], 1,3,4-thiadiazole [19], azolo[1,5- a ]pyrimidine [20], coumarin [21] derivatives displayed significant antitumor, cytotoxic, antiinflammatory, anticoagulant, antioxidant, antifungal, antitubercular, anticonvulsant, antimicrobial, antiviral, neuroprotective and diuretic activities. In continuation of our research program on the synthesis of novel heterocyclic compounds exhibiting antitumor activities [22,23,24,25,26], we attempted to design pyrazolo[1,5- a ]pyrimidine, tetrazolo[1,5- a ]-pyrimidine, imidazo[1,2- a ]pyrimidine, pyrazolo[3,4- d ]pyridazine, thiazoles, and thiadiazoles linked to position 3 of coumarin as a novel 3-heteroarylcoumarins, which have not been reported hitherto, to evaluate their in vitro antitumor activity against a liver carcinoma cell line (HEPG2-1).…”